Every citizen relies on the availability of safe medicines. Fake drug trafficking is a lucrative business growing every year throughout the world. It leads to therapeutic failure, pharmacological resistance, and financial ruin. Corruption, insufficient technology for protecting the identification of legitimate pharmaceuticals, and a lack of political will, especially a lack of vigilance and lobbying by healthcare providers, are some of the key causes of widespread drug counterfeiting. Authenticating fake medicines requires both local and international efforts.
Falsified and substandard medications may contain hazardous dosages of harmful substances, resulting in mass poisoning.
Poor-quality drugs jeopardise chronic and infectious illness treatment, leading to disease progression, drug resistance, and mortality.
As the prevalence of chronic diseases rises in low- and middle-income nations, so will the demand for safe and effective treatments.
Substandard and counterfeit pharmaceuticals promote drug resistance, endangering people's health now and in the future.
Counterfeit pharmaceuticals endanger public health, squander consumer money, and undermine the incentive to invest in research and development. It would be beneficial if drug vendors were subjected to more stringent state licensure oversight. Technological solutions, such as Radio Frequency Identification (RFID) devices, should also be examined. Finally, counterfeit pharmaceuticals may create consumer concerns about safety and decrease patient adherence to therapy.
Comments
Post a Comment